SEC Form 4Coverage since May 11, 2026
$CVKD insider trading
Over the last 12 months, Cadrenal Therapeutics insiders reported no purchases and 15 sales totaling $388K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $388K 15 events
- Events · 12m
- 15 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $CVKD · 12Mvia TradingView
Top insiders · 12m
Pham Quang XCEO and Chairman9× · $115K
Pham Quang XChairman, CEO and Interim CFO5× · $251K
Pham Quang XChairman and CEO1× · $22K
All insider trades
15 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Pham Quang XChairman and CEO · O·D·10% | ▼ Sale | 7,400 | $3.03 | $22K | -7% | plan |
| Jun 26, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 11,156 | $3.04 | $34K | -9.5% | plan · 2 tranches |
| Jun 23, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 11,444 | $3.48 | $40K | -8.9% | plan · 2 tranches |
| Jun 17, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 4,126 | $3.18 | $13K | -3.1% | plan · 2 tranches |
| Jun 15, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 18,124 | $3.88 | $70K | -12% | plan · 3 tranches |
| Jun 10, 2026 | Pham Quang XChairman, CEO and Interim CFO · O·D·10% | ▼ Sale | 22,385 | $4.17 | $93K | -12.9% | plan · 3 tranches |
| Jun 5, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 2,064 | $4.42 | $9K | -1.2% | plan |
| Jun 4, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 3,898 | $4.41 | $17K | -2.2% | plan |
| Jun 3, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 2,323 | $4.26 | $10K | -1.3% | plan |
| Jun 2, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 349 | $4.46 | $2K | -0.2% | plan |
| May 29, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 303 | $5.01 | $2K | -0.2% | plan |
| May 28, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 2,989 | $4.93 | $15K | -1.6% | plan |
| May 22, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 1,165 | $5.69 | $7K | -0.6% | plan |
| May 12, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 3,298 | $5.28 | $17K | -1.8% | plan · late |
| May 11, 2026 | Pham Quang XCEO and Chairman · O·D·10% | ▼ Sale | 6,476 | $5.76 | $37K | -3.3% | plan · late |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CVKD feed.